attention us:
Product Catalogue
Contact information
Welcome to call the service hotline



Nervous system

Location>Home>Nervous system>N009:ALS panel


    Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), the cause is still unknown. 20% of cases may be related to genetic defects. In addition, some environmental factors, such as genetics, heavy metal poisoning, may cause motor neuron damage. Genetic testing of amyotrophic lateral sclerosis is to use the target area capture technology and high-throughput sequencing technology, to detect and analysis the related genes of client's amyotrophic lateral sclerosis. And in the meantime, it can be in early screening of patients with amyotrophic lateral sclerosis, as well as to realize individualized medication and specificity of gene therapy to provide important basis for patients through combining with the history, clinical manifestation and information. Mygenostics is aimed to detect and analysis multiple subtypes of amyotrophic lateral sclerosis by hand in hand with clinical experts, combined with a new generation of high-throughput sequencing technology and bioinformatics analysis, to provide reliable basis for early diagnosis of amyotrophic lateral sclerosis patients.

Amyotrophy amyotrophic lateral sclerosis (ALS) panel covers four kinds of muscle atrophy amyotrophic lateral sclerosis, the scope contains all the genes encoding exons zone and shear zone

1 Muscle atrophy amyotrophic lateral sclerosis type 2-21
2 Muscle atrophy amyotrophic lateral sclerosis, related risk
3 The frontal lobe dementia
4 The differential diagnosis related genes